Share Price and Basic Stock Data
Last Updated: December 12, 2025, 8:27 pm
| PEG Ratio | -0.15 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Mysore Petro Chemicals Ltd operates in the organic chemicals sector, specifically focusing on Maleic Anhydride, a key raw material used in various industrial applications. The company has seen a fluctuating revenue trajectory over the past few years. For instance, sales reported for FY 2023 stood at ₹18.41 Cr, down from ₹20.90 Cr in FY 2022. However, a notable rebound is observed in the trailing twelve months (TTM) where revenues have risen to ₹30.25 Cr, suggesting a potential recovery in demand. The quarterly sales data reveals a significant jump in March 2024, reaching ₹15.18 Cr, indicating a strong performance relative to prior quarters. This fluctuation could be attributed to changes in market dynamics, competitive pressures, or operational challenges, all of which investors should consider when evaluating the company’s growth prospects.
Profitability and Efficiency Metrics
Profitability remains a concern for Mysore Petro Chemicals, with the company reporting a net profit of -₹6.86 Cr for FY 2025. The operating profit margin (OPM) has been particularly strained, recorded at -33.06%, reflecting ongoing operational inefficiencies. Despite a brief spike in profitability in March 2024, where the company recorded an operating loss of ₹3.74 Cr, the overall trend suggests that the company is struggling to control costs effectively. The interest coverage ratio, however, stood at a robust 62.63x, indicating that the company is comfortably meeting its interest obligations, which is a positive sign amidst its profitability challenges. Investors should weigh these profitability metrics against the backdrop of rising revenues to gauge the overall health of the business.
Balance Sheet Strength and Financial Ratios
The balance sheet of Mysore Petro Chemicals presents a mixed picture. With total reserves of ₹212.46 Cr and minimal borrowings of ₹0.19 Cr, the company appears to be in a comfortable position regarding debt. This low leverage could provide a cushion against financial volatility. However, the return on equity (ROE) is a mere 1.30%, indicating that shareholder returns are weak relative to the capital employed. The price-to-book value ratio at 0.37x further underscores that the stock is trading at a significant discount to its book value, potentially attracting value investors. Yet, the current ratio of 3.98x suggests that the company holds ample liquidity, which is essential for covering short-term obligations and could be leveraged for operational improvements.
Shareholding Pattern and Investor Confidence
Mysore Petro Chemicals has a stable shareholding pattern, with promoters holding a significant 72.99% stake, reflecting strong insider confidence in the business. However, foreign institutional investors (FIIs) currently hold only 3.03%, with domestic institutional investors (DIIs) at a mere 0.44%. This low institutional interest could raise red flags for potential retail investors, as it may signal a lack of broader market confidence. The number of shareholders has increased to 5,944, indicating a growing interest from the public, which may provide some support for the stock. Nonetheless, the high promoter holding also raises concerns regarding liquidity and the potential for price manipulation, which investors should monitor closely.
Outlook, Risks, and Final Insight
The outlook for Mysore Petro Chemicals hinges on its ability to stabilize operations and enhance profitability. While the recent uptick in sales is promising, the persistent losses and low ROE present significant risks. Investors should be cautious, as fluctuations in raw material prices or operational disruptions could further impact margins. Additionally, the dependency on a narrow product range in a competitive industry poses inherent risks. Nevertheless, the company’s strong balance sheet and low debt levels provide a buffer against financial distress. As such, retail investors might view this stock as a speculative play, trading at a discount but facing substantial operational hurdles that necessitate careful monitoring and analysis.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mysore Petro Chemicals Ltd | 68.7 Cr. | 104 | 174/99.0 | 8.32 | 333 | 1.92 % | 7.82 % | 1.30 % | 10.0 |
| I G Petrochemicals Ltd | 1,256 Cr. | 407 | 604/361 | 29.9 | 419 | 2.45 % | 11.4 % | 8.53 % | 10.0 |
| Industry Average | 1,256.00 Cr | 255.50 | 19.11 | 376.00 | 2.19% | 9.61% | 4.92% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.45 | 8.33 | 2.18 | 6.46 | 0.00 | 7.08 | 5.79 | 15.18 | 13.89 | 9.16 | 6.39 | 7.44 | 7.26 |
| Expenses | 3.71 | 8.99 | 3.76 | 10.65 | 1.54 | 7.78 | 8.69 | 18.92 | 18.44 | 10.64 | 7.59 | 8.04 | 9.66 |
| Operating Profit | -2.26 | -0.66 | -1.58 | -4.19 | -1.54 | -0.70 | -2.90 | -3.74 | -4.55 | -1.48 | -1.20 | -0.60 | -2.40 |
| OPM % | -155.86% | -7.92% | -72.48% | -64.86% | -9.89% | -50.09% | -24.64% | -32.76% | -16.16% | -18.78% | -8.06% | -33.06% | |
| Other Income | 11.95 | 8.64 | 6.60 | 9.42 | 8.72 | 3.07 | 3.03 | 4.48 | 19.59 | 0.38 | -7.80 | 4.01 | 2.36 |
| Interest | 0.12 | 0.19 | 0.12 | 0.16 | 0.04 | 0.01 | 0.03 | 0.20 | 0.40 | 0.02 | 0.02 | 0.02 | 0.02 |
| Depreciation | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.46 | 1.00 | 0.09 | 0.09 | 0.09 | 0.09 |
| Profit before tax | 9.46 | 7.68 | 4.79 | 4.96 | 7.03 | 2.25 | -0.01 | 0.08 | 13.64 | -1.21 | -9.11 | 3.30 | -0.15 |
| Tax % | 25.05% | 17.19% | 18.58% | 32.06% | 25.60% | -3.11% | 200.00% | 925.00% | 35.78% | 107.44% | -31.83% | 31.52% | 166.67% |
| Net Profit | 7.08 | 6.37 | 3.90 | 3.37 | 5.23 | 2.32 | -0.03 | -0.67 | 8.75 | -2.51 | -6.21 | 2.26 | -0.40 |
| EPS in Rs | 10.75 | 9.68 | 5.92 | 5.12 | 7.94 | 3.52 | -0.05 | -0.08 | 14.43 | -3.81 | -9.43 | 3.43 | -0.61 |
Last Updated: August 19, 2025, 1:15 pm
Below is a detailed analysis of the quarterly data for Mysore Petro Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 7.26 Cr.. The value appears to be declining and may need further review. It has decreased from 7.44 Cr. (Mar 2025) to 7.26 Cr., marking a decrease of 0.18 Cr..
- For Expenses, as of Jun 2025, the value is 9.66 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.04 Cr. (Mar 2025) to 9.66 Cr., marking an increase of 1.62 Cr..
- For Operating Profit, as of Jun 2025, the value is -2.40 Cr.. The value appears to be declining and may need further review. It has decreased from -0.60 Cr. (Mar 2025) to -2.40 Cr., marking a decrease of 1.80 Cr..
- For OPM %, as of Jun 2025, the value is -33.06%. The value appears to be declining and may need further review. It has decreased from -8.06% (Mar 2025) to -33.06%, marking a decrease of 25.00%.
- For Other Income, as of Jun 2025, the value is 2.36 Cr.. The value appears to be declining and may need further review. It has decreased from 4.01 Cr. (Mar 2025) to 2.36 Cr., marking a decrease of 1.65 Cr..
- For Interest, as of Jun 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.09 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.09 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 3.30 Cr. (Mar 2025) to -0.15 Cr., marking a decrease of 3.45 Cr..
- For Tax %, as of Jun 2025, the value is 166.67%. The value appears to be increasing, which may not be favorable. It has increased from 31.52% (Mar 2025) to 166.67%, marking an increase of 135.15%.
- For Net Profit, as of Jun 2025, the value is -0.40 Cr.. The value appears to be declining and may need further review. It has decreased from 2.26 Cr. (Mar 2025) to -0.40 Cr., marking a decrease of 2.66 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.61. The value appears to be declining and may need further review. It has decreased from 3.43 (Mar 2025) to -0.61, marking a decrease of 4.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 12:53 pm
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.30 | 6.23 | 32.58 | 12.98 | 22.84 | 20.90 | 18.41 | 25.80 | 33.48 | 30.25 |
| Expenses | 24.60 | 9.79 | 35.95 | 15.53 | 24.98 | 23.65 | 25.55 | 30.25 | 39.07 | 35.93 |
| Operating Profit | 5.70 | -3.56 | -3.37 | -2.55 | -2.14 | -2.75 | -7.14 | -4.45 | -5.59 | -5.68 |
| OPM % | 18.81% | -57.14% | -10.34% | -19.65% | -9.37% | -13.16% | -38.78% | -17.25% | -16.70% | -18.78% |
| Other Income | 13.98 | 93.03 | 22.59 | 8.64 | 27.00 | 46.19 | 35.05 | 14.98 | 13.39 | -1.05 |
| Interest | 1.20 | 0.07 | 0.04 | 0.06 | 0.34 | 0.26 | 0.58 | 0.12 | 0.07 | 0.08 |
| Depreciation | 2.93 | 0.78 | 0.68 | 0.63 | 0.60 | 0.59 | 0.43 | 0.45 | 0.37 | 0.36 |
| Profit before tax | 15.55 | 88.62 | 18.50 | 5.40 | 23.92 | 42.59 | 26.90 | 9.96 | 7.36 | -7.17 |
| Tax % | 5.59% | 19.15% | 4.00% | 10.00% | 109.32% | 23.24% | 22.97% | 25.00% | 58.70% | |
| Net Profit | 14.68 | 71.65 | 17.76 | 4.86 | -2.24 | 32.69 | 20.72 | 7.47 | 3.04 | -6.86 |
| EPS in Rs | 22.30 | 108.83 | 26.98 | 7.38 | -3.40 | 49.65 | 31.47 | 11.35 | 4.62 | -10.42 |
| Dividend Payout % | 4.49% | 1.84% | 7.42% | 27.12% | -58.84% | 5.04% | 7.95% | 22.05% | 43.36% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 388.08% | -75.21% | -72.64% | -146.09% | 1559.38% | -36.62% | -63.95% | -59.30% |
| Change in YoY Net Profit Growth (%) | 0.00% | -463.29% | 2.58% | -73.46% | 1705.47% | -1595.99% | -27.33% | 4.64% |
Mysore Petro Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | 17% |
| TTM: | -28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -9% |
| 3 Years: | -55% |
| TTM: | 223% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 19% |
| 3 Years: | 2% |
| 1 Year: | -47% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | 4% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 3:46 pm
Balance Sheet
Last Updated: December 4, 2025, 3:06 am
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 | 6.59 |
| Reserves | 69.65 | 140.67 | 156.89 | 160.12 | 156.67 | 187.98 | 207.09 | 213.66 | 214.10 | 212.46 |
| Borrowings | 6.17 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.31 | 0.22 | 0.19 |
| Other Liabilities | 10.47 | 4.66 | 5.97 | 6.11 | 30.88 | 39.59 | 44.64 | 63.60 | 52.03 | 48.76 |
| Total Liabilities | 92.88 | 152.24 | 169.45 | 172.82 | 194.14 | 234.16 | 258.32 | 304.16 | 272.94 | 268.00 |
| Fixed Assets | 32.50 | 18.83 | 16.30 | 15.67 | 15.07 | 15.77 | 15.34 | 47.51 | 14.50 | 14.36 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 2.02 | 0.00 | 0.00 |
| Investments | 53.95 | 79.42 | 107.18 | 115.48 | 144.94 | 213.33 | 227.90 | 231.64 | 241.55 | 234.82 |
| Other Assets | 6.43 | 53.99 | 45.97 | 41.67 | 34.13 | 5.06 | 14.78 | 22.99 | 16.89 | 18.82 |
| Total Assets | 92.88 | 152.24 | 169.45 | 172.82 | 194.14 | 234.16 | 258.32 | 304.16 | 272.94 | 268.00 |
Below is a detailed analysis of the balance sheet data for Mysore Petro Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6.59 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.59 Cr..
- For Reserves, as of Sep 2025, the value is 212.46 Cr.. The value appears to be declining and may need further review. It has decreased from 214.10 Cr. (Mar 2025) to 212.46 Cr., marking a decrease of 1.64 Cr..
- For Borrowings, as of Sep 2025, the value is 0.19 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.22 Cr. (Mar 2025) to 0.19 Cr., marking a decrease of 0.03 Cr..
- For Other Liabilities, as of Sep 2025, the value is 48.76 Cr.. The value appears to be improving (decreasing). It has decreased from 52.03 Cr. (Mar 2025) to 48.76 Cr., marking a decrease of 3.27 Cr..
- For Total Liabilities, as of Sep 2025, the value is 268.00 Cr.. The value appears to be improving (decreasing). It has decreased from 272.94 Cr. (Mar 2025) to 268.00 Cr., marking a decrease of 4.94 Cr..
- For Fixed Assets, as of Sep 2025, the value is 14.36 Cr.. The value appears to be declining and may need further review. It has decreased from 14.50 Cr. (Mar 2025) to 14.36 Cr., marking a decrease of 0.14 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 234.82 Cr.. The value appears to be declining and may need further review. It has decreased from 241.55 Cr. (Mar 2025) to 234.82 Cr., marking a decrease of 6.73 Cr..
- For Other Assets, as of Sep 2025, the value is 18.82 Cr.. The value appears strong and on an upward trend. It has increased from 16.89 Cr. (Mar 2025) to 18.82 Cr., marking an increase of 1.93 Cr..
- For Total Assets, as of Sep 2025, the value is 268.00 Cr.. The value appears to be declining and may need further review. It has decreased from 272.94 Cr. (Mar 2025) to 268.00 Cr., marking a decrease of 4.94 Cr..
Notably, the Reserves (212.46 Cr.) exceed the Borrowings (0.19 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.47 | -3.88 | -3.37 | -2.55 | -2.14 | -2.75 | -7.14 | -24.76 | -5.81 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 19.76 | 0.00 | 4.37 | 20.53 | 77.67 | 29.34 | 104.09 | 137.79 | 86.45 |
| Inventory Days | 146.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 27.01 | 0.00 |
| Days Payable | 149.60 | 26.12 | |||||||
| Cash Conversion Cycle | 16.99 | 0.00 | 4.37 | 20.53 | 77.67 | 29.34 | 104.09 | 138.68 | 86.45 |
| Working Capital Days | -45.66 | 642.12 | 138.92 | 410.84 | 290.37 | -6.46 | 81.88 | -84.74 | 28.67 |
| ROCE % | 20.91% | 11.47% | 3.12% | 18.92% | 23.58% | 12.26% | 4.94% | 7.82% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.62 | 11.35 | 31.48 | 49.66 | -3.41 |
| Diluted EPS (Rs.) | 4.62 | 11.35 | 31.48 | 49.66 | -3.41 |
| Cash EPS (Rs.) | -16.65 | 3.67 | -8.06 | -2.59 | -29.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 335.00 | 337.31 | 324.36 | 295.36 | 247.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 335.00 | 337.31 | 324.36 | 295.36 | 247.83 |
| Revenue From Operations / Share (Rs.) | 50.82 | 42.58 | 27.95 | 31.73 | 34.67 |
| PBDIT / Share (Rs.) | 6.53 | 7.88 | 2.20 | 12.82 | -0.04 |
| PBIT / Share (Rs.) | 5.97 | 6.67 | 1.55 | 11.92 | -0.95 |
| PBT / Share (Rs.) | 6.20 | 6.24 | 0.66 | 11.53 | -1.48 |
| Net Profit / Share (Rs.) | -17.21 | 2.46 | -8.71 | -3.49 | -41.18 |
| NP After MI And SOA / Share (Rs.) | 4.62 | 11.34 | 31.45 | 49.63 | -3.40 |
| PBDIT Margin (%) | 12.85 | 18.51 | 7.87 | 40.41 | -0.13 |
| PBIT Margin (%) | 11.75 | 15.66 | 5.55 | 37.56 | -2.76 |
| PBT Margin (%) | 12.19 | 14.64 | 2.38 | 36.34 | -4.25 |
| Net Profit Margin (%) | -33.86 | 5.77 | -31.17 | -11.01 | -118.78 |
| NP After MI And SOA Margin (%) | 9.09 | 26.63 | 112.53 | 156.42 | -9.82 |
| Return on Networth / Equity (%) | 1.37 | 3.39 | 9.69 | 16.80 | -1.37 |
| Return on Capital Employeed (%) | 1.47 | 1.55 | 0.40 | 3.39 | -0.33 |
| Return On Assets (%) | 1.11 | 2.45 | 8.02 | 13.96 | -1.15 |
| Asset Turnover Ratio (%) | 0.11 | 0.09 | 0.10 | 0.14 | 0.17 |
| Current Ratio (X) | 3.98 | 1.41 | 13.06 | 7.26 | 8.24 |
| Quick Ratio (X) | 3.98 | 1.33 | 13.06 | 7.26 | 8.24 |
| Inventory Turnover Ratio (X) | 36.58 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 54.08 | 22.02 | 7.94 | 4.02 | -58.68 |
| Dividend Payout Ratio (CP) (%) | 48.23 | 19.89 | 7.78 | 3.95 | 24.82 |
| Earning Retention Ratio (%) | 45.92 | 77.98 | 92.06 | 95.98 | 158.68 |
| Cash Earning Retention Ratio (%) | 51.77 | 80.11 | 92.22 | 96.05 | 75.18 |
| Interest Coverage Ratio (X) | 62.63 | 18.20 | 2.49 | 32.94 | -0.08 |
| Interest Coverage Ratio (Post Tax) (X) | -5.62 | 6.68 | -8.84 | -7.98 | -78.58 |
| Enterprise Value (Cr.) | 75.36 | 112.03 | 65.88 | 67.57 | 47.69 |
| EV / Net Operating Revenue (X) | 2.25 | 3.99 | 3.58 | 3.23 | 2.09 |
| EV / EBITDA (X) | 17.51 | 21.57 | 45.45 | 8.00 | -1563.51 |
| MarketCap / Net Operating Revenue (X) | 2.44 | 4.13 | 3.97 | 3.28 | 2.17 |
| Retention Ratios (%) | 45.91 | 77.97 | 92.05 | 95.97 | 158.68 |
| Price / BV (X) | 0.37 | 0.52 | 0.34 | 0.35 | 0.30 |
| Price / Net Operating Revenue (X) | 2.44 | 4.13 | 3.97 | 3.28 | 2.17 |
| EarningsYield | 0.03 | 0.06 | 0.28 | 0.47 | -0.04 |
After reviewing the key financial ratios for Mysore Petro Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.62. This value is below the healthy minimum of 5. It has decreased from 11.35 (Mar 24) to 4.62, marking a decrease of 6.73.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.62. This value is below the healthy minimum of 5. It has decreased from 11.35 (Mar 24) to 4.62, marking a decrease of 6.73.
- For Cash EPS (Rs.), as of Mar 25, the value is -16.65. This value is below the healthy minimum of 3. It has decreased from 3.67 (Mar 24) to -16.65, marking a decrease of 20.32.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 335.00. It has decreased from 337.31 (Mar 24) to 335.00, marking a decrease of 2.31.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 335.00. It has decreased from 337.31 (Mar 24) to 335.00, marking a decrease of 2.31.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 50.82. It has increased from 42.58 (Mar 24) to 50.82, marking an increase of 8.24.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 6.53. This value is within the healthy range. It has decreased from 7.88 (Mar 24) to 6.53, marking a decrease of 1.35.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.97. This value is within the healthy range. It has decreased from 6.67 (Mar 24) to 5.97, marking a decrease of 0.70.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.20. This value is within the healthy range. It has decreased from 6.24 (Mar 24) to 6.20, marking a decrease of 0.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -17.21. This value is below the healthy minimum of 2. It has decreased from 2.46 (Mar 24) to -17.21, marking a decrease of 19.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.62. This value is within the healthy range. It has decreased from 11.34 (Mar 24) to 4.62, marking a decrease of 6.72.
- For PBDIT Margin (%), as of Mar 25, the value is 12.85. This value is within the healthy range. It has decreased from 18.51 (Mar 24) to 12.85, marking a decrease of 5.66.
- For PBIT Margin (%), as of Mar 25, the value is 11.75. This value is within the healthy range. It has decreased from 15.66 (Mar 24) to 11.75, marking a decrease of 3.91.
- For PBT Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has decreased from 14.64 (Mar 24) to 12.19, marking a decrease of 2.45.
- For Net Profit Margin (%), as of Mar 25, the value is -33.86. This value is below the healthy minimum of 5. It has decreased from 5.77 (Mar 24) to -33.86, marking a decrease of 39.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.09. This value is within the healthy range. It has decreased from 26.63 (Mar 24) to 9.09, marking a decrease of 17.54.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 15. It has decreased from 3.39 (Mar 24) to 1.37, marking a decrease of 2.02.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 10. It has decreased from 1.55 (Mar 24) to 1.47, marking a decrease of 0.08.
- For Return On Assets (%), as of Mar 25, the value is 1.11. This value is below the healthy minimum of 5. It has decreased from 2.45 (Mar 24) to 1.11, marking a decrease of 1.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.11. It has increased from 0.09 (Mar 24) to 0.11, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 3.98. This value exceeds the healthy maximum of 3. It has increased from 1.41 (Mar 24) to 3.98, marking an increase of 2.57.
- For Quick Ratio (X), as of Mar 25, the value is 3.98. This value exceeds the healthy maximum of 2. It has increased from 1.33 (Mar 24) to 3.98, marking an increase of 2.65.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 36.58. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 36.58, marking an increase of 36.58.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 54.08. This value exceeds the healthy maximum of 50. It has increased from 22.02 (Mar 24) to 54.08, marking an increase of 32.06.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 48.23. This value is within the healthy range. It has increased from 19.89 (Mar 24) to 48.23, marking an increase of 28.34.
- For Earning Retention Ratio (%), as of Mar 25, the value is 45.92. This value is within the healthy range. It has decreased from 77.98 (Mar 24) to 45.92, marking a decrease of 32.06.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 51.77. This value is within the healthy range. It has decreased from 80.11 (Mar 24) to 51.77, marking a decrease of 28.34.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 62.63. This value is within the healthy range. It has increased from 18.20 (Mar 24) to 62.63, marking an increase of 44.43.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -5.62. This value is below the healthy minimum of 3. It has decreased from 6.68 (Mar 24) to -5.62, marking a decrease of 12.30.
- For Enterprise Value (Cr.), as of Mar 25, the value is 75.36. It has decreased from 112.03 (Mar 24) to 75.36, marking a decrease of 36.67.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.25. This value is within the healthy range. It has decreased from 3.99 (Mar 24) to 2.25, marking a decrease of 1.74.
- For EV / EBITDA (X), as of Mar 25, the value is 17.51. This value exceeds the healthy maximum of 15. It has decreased from 21.57 (Mar 24) to 17.51, marking a decrease of 4.06.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.44. This value is within the healthy range. It has decreased from 4.13 (Mar 24) to 2.44, marking a decrease of 1.69.
- For Retention Ratios (%), as of Mar 25, the value is 45.91. This value is within the healthy range. It has decreased from 77.97 (Mar 24) to 45.91, marking a decrease of 32.06.
- For Price / BV (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.52 (Mar 24) to 0.37, marking a decrease of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.44. This value is within the healthy range. It has decreased from 4.13 (Mar 24) to 2.44, marking a decrease of 1.69.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mysore Petro Chemicals Ltd:
- Net Profit Margin: -33.86%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.47% (Industry Average ROCE: 9.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.37% (Industry Average ROE: 4.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -5.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 8.32 (Industry average Stock P/E: 19.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -33.86%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Maleic Anhydride | D/4, Jyothi Complex, 134/1, Infantry Road, Bengaluru Karnataka 560001 | mpcl@mysorepetro.com http://www.mysorepetro.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Vaijayanti Pandit | Chairperson & Independent Director |
| Mr. Nikunj Dhanuka | Non Executive Director |
| Mr. Mayank Dhanuka | Non Executive Director |
| Mr. Satyanarayan Bankatlal Maheshwari | Executive Director |
| Mr. Shanti Kumar Loonker | Independent Director |
| Mrs. Uma Acharya | Independent Director |
FAQ
What is the intrinsic value of Mysore Petro Chemicals Ltd?
Mysore Petro Chemicals Ltd's intrinsic value (as of 12 December 2025) is 29.37 which is 71.76% lower the current market price of 104.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 68.7 Cr. market cap, FY2025-2026 high/low of 174/99.0, reserves of ₹212.46 Cr, and liabilities of 268.00 Cr.
What is the Market Cap of Mysore Petro Chemicals Ltd?
The Market Cap of Mysore Petro Chemicals Ltd is 68.7 Cr..
What is the current Stock Price of Mysore Petro Chemicals Ltd as on 12 December 2025?
The current stock price of Mysore Petro Chemicals Ltd as on 12 December 2025 is 104.
What is the High / Low of Mysore Petro Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mysore Petro Chemicals Ltd stocks is 174/99.0.
What is the Stock P/E of Mysore Petro Chemicals Ltd?
The Stock P/E of Mysore Petro Chemicals Ltd is 8.32.
What is the Book Value of Mysore Petro Chemicals Ltd?
The Book Value of Mysore Petro Chemicals Ltd is 333.
What is the Dividend Yield of Mysore Petro Chemicals Ltd?
The Dividend Yield of Mysore Petro Chemicals Ltd is 1.92 %.
What is the ROCE of Mysore Petro Chemicals Ltd?
The ROCE of Mysore Petro Chemicals Ltd is 7.82 %.
What is the ROE of Mysore Petro Chemicals Ltd?
The ROE of Mysore Petro Chemicals Ltd is 1.30 %.
What is the Face Value of Mysore Petro Chemicals Ltd?
The Face Value of Mysore Petro Chemicals Ltd is 10.0.